WASHINGTON D.C. – September 20, 2011– Dan Gustafson, who is heading an American Antitrust Institute Pharmacy Benefit Manager Merger Ad Hoc Working Group, testified before the House Judiciary Subcommittee on Intellectual Property, Competition and Internet at the hearing on “The Proposed Merger between Express Scripts and Medco” in his individual capacity as an antitrust practitioner, raising concerns regarding the possible anticompetitive effects of a merger between two of the three largest pharmacy benefit managers.
C-Span Video of PBM Merger Hearing
PBM Merger Testimony of Dan Gustafson
